Anúncio
Anúncio

ACET

ACET logo

Adicet Bio, Inc. Common Stock

8.02
USD
Patrocinado
-0.07
-0.82%
09 de jan., 15:59 UTC -5
Encerrado
exchange

Pós-Mercado

8.05

+0.03
+0.32%

Relatórios de Lucros ACET

Rácio de surpresa positiva

ACET separação 16 de 32 últimas estimativas.

50%

Próximo Relatório

Data do Próximo Relatório
04 de mar. de 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$0.19
Mudanças implicadas de Q3 25 (Revenue/ EPS)
--
/
-32.14%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
--
/
-40.63%

Adicet Bio, Inc. Common Stock earnings per share and revenue

On 05 de nov. de 2025, ACET reported earnings of -0.28 USD per share (EPS) for Q3 25, beating the estimate of -0.29 USD, resulting in a 1.86% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -1.91% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 9 analistas forecast an EPS of -0.19 USD, with revenue projected to reach -- USD, implying an diminuir of -32.14% EPS, and aumentar of 0.00% in Revenue from the last quarter.
FAQ
For Q3 2025, Adicet Bio, Inc. Common Stock reported EPS of -$0.28, beating estimates by 1.86%, and revenue of $0.00, 0% as expectations.
The stock price moved down -1.91%, changed from $11.04 before the earnings release to $10.83 the day after.
The next earning report is scheduled for 04 de mar. de 2026.
Based on 9 analistas, Adicet Bio, Inc. Common Stock is expected to report EPS of -$0.19 and revenue of -- for Q4 2025.
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio